{
    "2021-01-14": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Beigene Stock Breaks Out To Record High On Cancer Drug OK In China",
                "features": {
                    "keywords": [
                        "Beigene",
                        "record high",
                        "cancer drug",
                        "approval",
                        "China"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "With Rare Speed, Gene Editing Emerges as Biotechâ€™s New Cutting Edge",
                "features": {
                    "keywords": [
                        "gene editing",
                        "biotech",
                        "cutting edge",
                        "rare speed"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "genomics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}